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Abstract
Background: Autologous skin grafting is an important modality for wound coverage; however, it can result in
donor site morbidity. Epidermal grafting is an emerging option to overcome this challenge. Furthermore, it can be
done in an outpatient setting with minimal or no pain. To date, the evidence on the efficacy of this technique for
wound healing has yet to be outlined. We aim to synthesise the current evidence on epidermal grafting for wound
healing to establish the efficacy of this technique.
Methods/design: We will conduct a comprehensive search in the MEDLINE, EMBASE, and CENTRAL databases (up to
May 2016) to identify studies on epidermal grafting for wound healing. We will include any primary studies (excluding
case reports or case series lesser than three patients) or systematic reviews of such studies to assess the outcome of
epidermal grafting for wound healing either on its own or compared to other methods. The expected primary outcome
measures are the efficacy of epidermal grafting for wound healing (measured by the proportion of wounds healed at
6 weeks) and the mean wound-healing time (time for complete re-epithelialisation). Secondary outcome measures are
the mean donor site-healing time, need for anaesthesia, costs associated with resource use, health-related quality of life,
and proportion of patients with adverse event. Subgroup analysis will be performed for the proportions of wounds
healed based on wound aetiology.
Discussion: This is a timely systematic review, and the finding of this systematic review is expected to guide research
and clinical practice aimed at improving wound care.
Systematic review registration: PROSPERO CRD42016033051
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Introduction
Autologous skin grafting is an important modality for
wound coverage [1]. It can be classified based on the thick-
ness of the harvested skin, namely, full-thickness skin graft
(FTSG), split-thickness skin graft (SSG), and epidermal
graft (EG) [2, 3].
FTSG consists of the epidermis and the entire dermis of
the skin. FTSG is harvested by surgical excision, and the
donor site requires primary closure. Thus, only selected
areas with sufficient skin laxity are suitable for skin harvest,
limiting this option for the coverage of small areas only [1].
Conversely, SSG involves the excision of the epidermis and
part of the dermis, using an electric air dermatome, leaving
behind the reticular dermis in the donor site enabling the
skin to heal by secondary intention [1]. It is the commonest
form of autologous skin grafting performed and can be
meshed to cover a wide surface area [1]. However, the
donor site becomes a second, often painful wound, which
may take more time to heal than the graft site itself and
holds the risk of infection and scarring [4]. Both the FTSG
and SSG often require hospital admission, even as a day
case, anaesthesia, and a period of immobility for some
patients.
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Epidermal grafting, on the other hand, is an emerging
and promising option to overcome these challenges. EG for
wound healing is relatively recent compared to FTSG and
SSG, which have been performed since the eighteenth cen-
tury [2, 5, 6]. EG involves harvesting only the epidermal
layer of the skin from the donor site by applying continuous
negative pressure on the normal skin to raise a blister. The
roof of the blister, which is the epidermis, is then excised
and transferred onto the wound. As the dermis in the
donor site remains untouched, the skin regenerates itself
without a scar. This procedure is also often painless as the
pain fibres in the dermis are unstimulated, allowing autolo-
gous skin grafting in the outpatient setting. The use of EG
for treating wounds has been on the rise of late, with
several recent publications in the last couple of years,
as it allows autologous skin grafting in the outpatient
setting without anaesthesia and with minimal donor
site morbidity [3, 7–11].
Although there are several reports on the successful
wound healing with epidermal grafting, to date, the evi-
dence on the efficacy of this technique for wound healing
has yet to be outlined. A scoping search was undertaken in
the MEDLINE (OvidSP), EMBASE (OvidSP), and Cochrane
Central Register of Controlled Trials (CENTRAL) data-
bases to identify existing systematic reviews and to gauge
the volume of any primary studies on the topic. No existing
systematic reviews were identified, but there are a number
of primary studies on epidermal grafting for wound healing.
It is timely that the evidence on the efficacy of this tech-
nique is assessed to guide clinical decision-making and
facilitate future intervention research.
Methods/design
Objective
This systematic review synthesises the current evidence on
epidermal grafting for wound healing to establish the effi-
cacy of this technique in the clinical setting by measuring
the proportion of wounds healed and the mean wound-
healing time (time for complete re-epithelialisation).
General methods
This protocol has been registered with the PROSPERO
international prospective register of systematic reviews
(registration number, CRD42016033051) and was reported
adhering to the Preferred Reporting Items for Systematic
Review and Meta-Analysis Protocols (PRISMA-P) 2015
statement (see Additional file 1) [12]. The final review will
be reported following the PRISMA statement. In the event
of no randomised controlled trial (RCT) available to be
included, the systematic review will be reported according
to the Meta-analysis Of Observational Studies in Epidemi-
ology (MOOSE) guidelines [13].
Search strategies
We will search the MEDLINE (OvidSP), EMBASE
(OvidSP), and CENTRAL databases from 1946 to identify
studies of relevance to this review. Publicly available trial
registers (ClinicalTrials.Gov and WHO International Clin-
ical Trials Registry Platform) will be searched for all trials.
The reference list of all articles included will be cross-
checked for further articles of relevance.
The search strategy will use a combination of text word
and Medical Subject Headings (MeSH) terms relating to
the use of epidermal graft in treating wounds. There will be
no restriction by study design or outcomes as the research
questions are broad. No date, language, or publication
restriction will be applied. A sample search strategy for
MEDLINE (OvidSP) is shown, and a similar strategy will be
adapted for use in other databases.
1. [epidermal graft*] OR [blister graft*] OR [suction
blister*] OR [suction graft*]
2. Epidermis/su, tr [Surgery, Transplantation]
3. [1] or [2]
Selection criteria
All human studies related to epidermal grafting for treating
wounds will be included.
Study design
We will include any primary studies (excluding case reports
or case series lesser than three patients), or systematic
reviews of such studies, assessing the outcome of epidermal
grafting for wound healing either on its own or compared
to other methods.
Type of participants
The participants are adult patients (18 years and above)
with wounds of any size and aetiology treated by epidermal
grafting.
Setting
Studies performed in any clinical setting will be included.
Intervention
This will include any epidermal graft-harvesting tech-
niques which involve creating suction blisters using nega-
tive pressure. Information about the harvest methods such
as the amount of negative pressure generated, harvest
device, harvest time, and dressing used after grafting will
be documented.
Comparator
Studies comparing epidermal grafting to wounds managed
by dressings only will be included in this review.
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Outcome measures
The primary outcome measures are the proportions of
wounds with complete healing at 6 weeks and the mean
wound-healing time (time for complete re-epithelialisation).
Secondary outcome measures are the mean donor site-
healing time, need for anaesthesia, economic evaluation
based on the cost associated with resource use, health-
related quality of life, and proportion of patients with ad-
verse event. Subgroup analysis will be performed for the
proportions of wounds with complete healing based on the
wound aetiology.
Exclusion criteria
The exclusion criteria are as follows: case series of less
than three cases; studies describing the use of epidermal
grafting in skin pigmentation disorder such as vitiligo;
and studies describing only the harvest technique with-
out treatment outcome.
Study selection and data management
Study selection will be conducted in a two-stage process.
The titles and abstracts will initially be screened by two
reviewers, using pre-specified screening criteria, for
potential eligibility after excluding duplicate records.
Next, studies identified as relevant will undergo full-text
review by both reviewers. Any discrepancies between the
reviewers will be resolved by discussion or by referral to
a third reviewer. Any relevant non-English language arti-
cles will be translated where necessary. The search re-
sults, including abstracts, full-text articles, and record of
the reviewer’s decisions, including reasons for exclusion,
will be recorded in Endnote X7.
Data extraction
The data from all full-text articles accepted for final analysis
will be independently retrieved by two authors using a stan-
dardised data extraction form. Any disagreements and dif-
ferences will be resolved by discussion or referral to a third
reviewer. Primary study authors will be contacted if further
information is needed or some data are missing.
The following data will be extracted:
 Study characteristics (authors, year of publication,
country of publication, study design)
 Patient demography (number of studied subjects, sex,
mean age, comorbidity, number of wounds treated)
 Wound characteristics (wound aetiology, mean
wound duration, mean wound size, pre-grafting
wound quality)
 Characteristics of intervention and control group
including the EG harvest technique (device used,
amount of negative pressure generated, duration of
harvest), use of anaesthesia, donor site dressing, and
wound dressing
 Outcomes (wound-healing time, number and type of
wounds with 100 % re-epithelialisation at 6 weeks,
number and type of wounds with 50–99 % healing at
6 weeks, number and type of wounds with lesser than
50 % healing at 6 weeks, donor site-healing time)
 Length of follow-up
 Cost for EG and dressings only for wound
management
 Health-related quality of life in patients managed
with EG and dressings only
 Complications or adverse events (incidence of device-
related adverse events (DAEs) and the incidence of
wound-related adverse events (WAEs) occurring
within the study duration)
 Statistical analysis model utilised
Assessment of risk of bias of included studies
Included studies will be critically appraised for methodo-
logical quality and risk of bias by two review authors
independently. Discrepancies will be resolved through
consensus or referral to a third reviewer if necessary.
The included studies are expected to all be observational
studies, with no RCTs. Should there be any RCTs, they
will be assessed according to the Cochrane Collaboration
Risk of Bias Assessment Tool [14]. The observational
cohort studies will be assessed using the Cochrane Risk
of Bias Assessment Tool for Non-Randomized Studies of
Interventions (ACROBAT-NRSI) [15]. This will evaluate
the risk of bias due to confounding, selection, measure-
ment, and interpretation. The quality of reporting will be
assessed using the Strengthening the Reporting of Obser-
vational Studies in Epidemiology (STROBE) checklist [16].
Data analysis and synthesis
The main outcome measure of the included studies will be
the pooled estimate of the proportions of wounds healed at
6 weeks, the mean wound-healing time, and the mean
donor site-healing time with corresponding 95 % confi-
dence intervals. Meta-analysis will be performed should a
sufficient number of studies with consistent characteristics
be found in terms of study design and outcome reporting.
We will explore the sources of potential clinical and meth-
odological heterogeneity based on the study design, popula-
tion, intervention, and comparator characteristics and
outcomes. Statistical heterogeneity will be assessed using
the chi-square test and quantified with the I2 statistic. The
thresholds for interpretation of I2 will be in accordance with
the definitions presented in the Cochrane Handbook for
Systematic Reviews of Interventions [17].
Narrative synthesis will be performed in the event that
the meta-analysis is not appropriate. The narrative synthe-
sis will be grouped by the outcome of interest. As several
different EG harvest devices are expected to be used, the
difference between the devices will likely be synthesised
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narratively. We also expect wounds from various aetiol-
ogies to be treated. The wounds will be broadly classified
into acute (<3 months in duration) and chronic (≥3 months
in duration), and the difference in outcome will then be
synthesised narratively.
Data synthesis will be performed using Review Manager
5.3 provided by The Cochrane Collaboration [17]. Should
no RCT be available, a meta-analysis of observational
study will be performed using StatsDirect Statistical soft-
ware (StatsDirect statistical software, version 2.8.0; Stats-
Direct, Altrincham, UK). The quality of evidence will be
rated using the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) approach.
Discussion
In this review, we aim to determine the efficacy of epi-
dermal grafting for wound healing by evaluating the
overall success rate of this technique for wound healing
and the mean wound and donor site-healing time which is
currently unclear. As epidermal grafting is now emerging
as a potential alternative to the more invasive traditional
techniques (FTSG and SSG), it is important that the
current literature on EG be evaluated to determine whether
its efficacy for wound healing is comparable or better than
the current treatment options. To our knowledge, this is
the first systematic review to outline the efficacy of epider-
mal grafting for wound healing. The finding of this system-
atic review is expected to guide research and clinical
practice aimed at improving wound care. In particular, if
epidermal grafting is efficacious for wound healing, it may
provide a cheaper and less invasive alternative to traditional
methods. It may also provide better donor site outcomes
and improved patient satisfaction due to less scarring and
pain.
Limitations
We expect the sensitivity of our search to be limited by the
lack of MeSH terms for epidermal grafting. We have in-
cluded a wide range of text word combinations to over-
come this.
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